These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 8542270)
1. Prospects for using a blood sample in the diagnosis of heart failure. Ulahannan TJ QJM; 1995 Nov; 88(11):845-6. PubMed ID: 8542270 [No Abstract] [Full Text] [Related]
2. Prospects for using a blood sample in the diagnosis of heart failure. Cheung BM QJM; 1995 Nov; 88(11):845; author reply 846. PubMed ID: 8542269 [No Abstract] [Full Text] [Related]
3. [B-type natriuretic peptide in the differential diagnosis of dyspnea: a useful aid or meaningless ornament? (see the article by Stejskal D. et al: "Personal experience with determination of NT-proBNP in clinical practice" in this issue of Vnitrní Lékarství]. Kölbel F Vnitr Lek; 2003 Feb; 49(2):94-6. PubMed ID: 12728574 [No Abstract] [Full Text] [Related]
4. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction. Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087 [TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease. Hess G; Runkel S; Zdunek D; Hitzler WE Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172 [TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure. Stoupakis G; Klapholz M Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635 [TBL] [Abstract][Full Text] [Related]
7. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy. Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441 [TBL] [Abstract][Full Text] [Related]
8. [Personal experience with determination of NT-proBNP in clinical practice]. Stejskal D; Oral I; Lacnák B; Juráková R; Horalík D; Adamovská S; Prosková J; Hrabovská I; Ozanová G Vnitr Lek; 2003 Feb; 49(2):121-6. PubMed ID: 12728579 [TBL] [Abstract][Full Text] [Related]
9. Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure. Davidson NC; Coutie WJ; Webb DJ; Struthers AD Heart; 1996 Jun; 75(6):576-81. PubMed ID: 8697160 [TBL] [Abstract][Full Text] [Related]
10. Elevated B-type natriuretic peptide levels after anthracycline administration. Suzuki T; Hayashi D; Yamazaki T; Mizuno T; Kanda Y; Komuro I; Kurabayashi M; Yamaoki K; Mitani K; Hirai H; Nagai R; Yazaki Y Am Heart J; 1998 Aug; 136(2):362-3. PubMed ID: 9704703 [TBL] [Abstract][Full Text] [Related]
12. [Recommendations for the clinical use of cardiac natriuretic peptides]. Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G Ital Heart J Suppl; 2005 May; 6(5):308-25. PubMed ID: 15934430 [No Abstract] [Full Text] [Related]
13. An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction. Hughes D; Talwar S; Squire IB; Davies JE; Ng LL Clin Sci (Lond); 1999 Apr; 96(4):373-80. PubMed ID: 10087244 [TBL] [Abstract][Full Text] [Related]
14. Screening for and treatment of left-ventricular abnormalities in diabetes mellitus. Chan NN; Chan JC Lancet; 2002 Oct; 360(9341):1251-2; author reply 1252. PubMed ID: 12401278 [No Abstract] [Full Text] [Related]
15. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure]. Song HM; Zhang J; Deng B; Luo M Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158 [TBL] [Abstract][Full Text] [Related]
16. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Tsutamoto T; Wada A; Maeda K; Hisanaga T; Mabuchi N; Hayashi M; Ohnishi M; Sawaki M; Fujii M; Horie H; Sugimoto Y; Kinoshita M Eur Heart J; 1999 Dec; 20(24):1799-807. PubMed ID: 10581138 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis of symptomless left ventricular dysfunction. Barnett DB Lancet; 1993 May; 341(8853):1124-5. PubMed ID: 8097808 [No Abstract] [Full Text] [Related]
18. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials. Saha SA; Molnar J; Arora RR Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of symptomless left ventricular dysfunction. Tan LB; Hall A Lancet; 1993 Jul; 342(8863):116-7. PubMed ID: 8100883 [No Abstract] [Full Text] [Related]
20. Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP. Birner CM; Ulucan C; Fredersdorf S; Rihm M; Löwel H; Stritzke J; Schunkert H; Hengstenberg C; Holmer S; Riegger G; Luchner A Cytokine; 2007 Nov; 40(2):89-97. PubMed ID: 17920926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]